Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea · Delayed Price · Currency is KRW 10,390
-140 (-1.33%)
Apr 2, 2026, 3:30 PM KST
Whan In Pharm Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 13,595 | 23,381 | 29,774 | 23,921 | 26,660 |
Depreciation & Amortization | 9,865 | 8,475 | 6,659 | 4,847 | 4,202 |
Loss (Gain) From Sale of Assets | 281.59 | 330.11 | 1,160 | 1,897 | 6.22 |
Loss (Gain) From Sale of Investments | - | -392.98 | -1,168 | 849.94 | -352.07 |
Loss (Gain) on Equity Investments | 199.72 | -1,981 | 1,006 | 201.08 | 61.86 |
Provision & Write-off of Bad Debts | 1,693 | 1,396 | 874.84 | 1,066 | 1,094 |
Other Operating Activities | 631.78 | 5,667 | 714.37 | -3,124 | -229.16 |
Change in Accounts Receivable | 7,450 | 1,088 | -7,320 | -10,221 | -56.46 |
Change in Inventory | -24,239 | -22,546 | -17,631 | -3,893 | 11.94 |
Change in Accounts Payable | 458.44 | 4,866 | 9,255 | 2,409 | 3,555 |
Change in Other Net Operating Assets | -892.06 | 411.23 | -128.37 | -1,102 | 365.9 |
Operating Cash Flow | 9,044 | 20,693 | 23,197 | 16,851 | 35,318 |
Operating Cash Flow Growth | -56.30% | -10.79% | 37.66% | -52.29% | 55.21% |
Capital Expenditures | -2,850 | -27,357 | -30,531 | -33,650 | -4,387 |
Sale of Property, Plant & Equipment | 0.55 | 3.95 | 88.74 | 80.44 | 34.75 |
Sale (Purchase) of Intangibles | -3,332 | -2,024 | -941.14 | -642.7 | -374.92 |
Sale (Purchase) of Real Estate | - | - | 153.69 | -33,466 | - |
Investment in Securities | 10,986 | 11,321 | 21,775 | 29,489 | 2,409 |
Other Investing Activities | -80.51 | -58 | 58.41 | -779.69 | 222.53 |
Investing Cash Flow | 4,747 | -18,095 | -9,432 | -38,942 | -2,122 |
Long-Term Debt Repaid | -539.92 | -465.53 | -414.47 | -549.98 | -613.78 |
Net Debt Issued (Repaid) | -539.92 | -465.53 | -414.47 | -549.98 | -613.78 |
Issuance of Common Stock | 11,396 | - | - | - | - |
Dividends Paid | -4,580 | -4,580 | -4,580 | -4,580 | -4,580 |
Other Financing Activities | 307.91 | -4.95 | -171.43 | - | - |
Financing Cash Flow | 6,584 | -5,051 | -5,166 | -5,130 | -5,194 |
Foreign Exchange Rate Adjustments | 58.17 | 233.66 | -8.58 | -59.27 | -19.77 |
Net Cash Flow | 20,433 | -2,219 | 8,591 | -27,280 | 27,982 |
Free Cash Flow | 6,194 | -6,664 | -7,334 | -16,799 | 30,931 |
Free Cash Flow Growth | - | - | - | - | 109.47% |
Free Cash Flow Margin | 2.43% | -2.57% | -3.18% | -8.44% | 17.40% |
Free Cash Flow Per Share | 390.61 | -436.48 | -480.39 | -1100.32 | 2025.98 |
Cash Interest Paid | 28.77 | 23.12 | 22.66 | 51.88 | 51.55 |
Cash Income Tax Paid | 5,179 | 5,094 | 5,009 | 8,354 | 8,107 |
Levered Free Cash Flow | 9,973 | -20,163 | -21,346 | -23,446 | 24,210 |
Unlevered Free Cash Flow | 9,991 | -20,148 | -21,332 | -23,414 | 24,242 |
Change in Working Capital | -17,223 | -16,181 | -15,824 | -12,807 | 3,876 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.